LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Weller J, Zeyen T, Schlegel U, Lazaridis L, Werner JM, Onken J, Zeiner P, Drexler R, Hau P, Seidel C, Grosse L, Clusmann H, Sabel M, Ringel F, Pichler J, Grauer O, Hundsberger T, Schnell O, Mair MJ, Uhl M, Schmidt-Graf F, Glas M, Galldiks N, Unteroberdoerster M, Steinbach J, Ricklefs F, Renovanz M, Delev DI, Turgut MO, Flesch OR, Cipriani D, Preusser M, Kebir S, Misch M, Goldbrunner R, Westphal M, Tabatabai G, Schaefer N, Schneider M, Vatter H, Giordano F, Schaub C, Herrlinger U (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: OXFORD UNIV PRESS INC

City/Town: CARY

Pages Range: 71-71

Conference Proceedings Title: NEURO-ONCOLOGY

Event location: Tampa, FL

DOI: 10.1093/neuonc/noac209.274

Authors with CRIS profile

Involved external institutions

Charité - Universitätsmedizin Berlin Germany (DE) Universitätsklinikum Regensburg Germany (DE) Universitätsklinikum Münster Germany (DE) Albert-Ludwigs-Universität Freiburg Germany (DE) Universitätsklinikum Tübingen Germany (DE) Universitätsklinikum Leipzig Germany (DE) Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz Germany (DE) Heinrich-Heine-Universität Düsseldorf Germany (DE) Medizinische Universität Wien Austria (AT) Universität zu Köln Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE) Universitätsklinikum Bonn Germany (DE) Universität Duisburg-Essen (UDE) Germany (DE) Technische Universität München (TUM) Germany (DE) Johannes Kepler Universität (JKU) Linz Austria (AT) Universitätsklinikum Frankfurt am Main (KGU) Germany (DE) Forschungszentrum Jülich / Research Centre Jülich (FZJ) Germany (DE) Kantonsspital St.Gallen Switzerland (CH) Ruhr-Universität Bochum (RUB) Germany (DE)

How to cite

APA:

Weller, J., Zeyen, T., Schlegel, U., Lazaridis, L., Werner, J.-M., Onken, J.,... Herrlinger, U. (2022). LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT. In NEURO-ONCOLOGY (pp. 71-71). Tampa, FL, US: CARY: OXFORD UNIV PRESS INC.

MLA:

Weller, Johannes, et al. "LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT." Proceedings of the 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), Tampa, FL CARY: OXFORD UNIV PRESS INC, 2022. 71-71.

BibTeX: Download